Aromatase Inhibitors—Induced Musculoskeletal Disorders: Current Knowledge on Clinical and Molecular Aspects

Aromatase inhibitors (AIs) have radically changed the prognosis of hormone receptor positive breast cancer (BC) in post-menopausal women, and are a mainstay of the adjuvant therapy for BC after surgery in place of, or following, Tamoxifen. However, AIs aren’t side effect-free; frequent adverse event...

Descripción completa

Detalles Bibliográficos
Autores principales: Tenti, Sara, Correale, Pierpaolo, Cheleschi, Sara, Fioravanti, Antonella, Pirtoli, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460580/
https://www.ncbi.nlm.nih.gov/pubmed/32781535
http://dx.doi.org/10.3390/ijms21165625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460580/
https://www.ncbi.nlm.nih.gov/pubmed/32781535
http://dx.doi.org/10.3390/ijms21165625

Ejemplares similares